New York lawmakers have scheduled a hearing to discuss the medical potential of psilocybin, with the Assembly Health Committee noting its "breakthrough therapy" designation by the FDA for major depression. The state is considering regulated access, with a meeting set for September 30 to discuss science and regulations. Various localities, including Colorado, Oregon, and New Mexico, already allow supervised use. Lawmakers have introduced bills to legalize psilocybin for adults and for therapeutic use in clinical or home settings.

New York Schedules Hearing on Psilocybin’s Medical Benefits and Risks

Sep 15, 2025

Source:

Kyle Jaeger

Marijuana Moment

New York is officially exploring the healing power of magic mushrooms. The State Assembly Health Committee has scheduled a hearing for September 30 to dive into the science and potential regulations surrounding psilocybin. While the feds still have it labeled as Schedule I, the FDA has already flagged it as a "breakthrough therapy" for depression. Lawmakers are looking at models from states like Colorado and Oregon to see how a supervised, regulated system could work for New Yorkers. There are even bills on the table to legalize natural psychedelics like DMT and ibogaine for adults.

This is a massive win for the community because it shows that the same momentum we built for cannabis is finally shifting toward other plant medicines. For tokers who value holistic wellness, this hearing is a huge step toward ending the broader drug war and opening up safe, legal access to natural alternatives. It’s about time the state recognizes that these ancient plants offer real relief for those struggling with mental health.